<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01958645</url>
  </required_header>
  <id_info>
    <org_study_id>D5050C00001</org_study_id>
    <nct_id>NCT01958645</nct_id>
  </id_info>
  <brief_title>To Assess Safety, Tolerability and Pharmacodynamics of Intravenous MEDI8111 After Single Ascending Doses.</brief_title>
  <official_title>A Phase I, Single-blind, Randomised, Placebo-controlled, Single Centre Study to Investigate the Safety, Tolerability and Pharmacodynamics of Intravenous MEDI8111 After Single Ascending Doses in Healthy Male Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AstraZeneca</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A study to investigate the safety, tolerability and pharmacodynamics of MEDI8111 after single
      ascending doses in healthy male.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A phase I, single-blind, randomised, placebo-controlled, single centre study to investigate
      the safety, tolerability and pharmacodynamics of intravenous MEDI8111 after single ascending
      doses in healthy male subjects.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Description of the Safety Profile in Terms of Adverse Events (AE),Vital Signs, ECG, Lab Variables, Immunogenicity and Physical Examination</measure>
    <time_frame>From screening and up to the lab follow-up visit (Day 29)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline Endogenous Thrombin Potential (ETP)</measure>
    <time_frame>Predose and Days 1-5</time_frame>
    <description>For the baseline variables and adverse events the two placebo arms (placebo dose 1 and placebo dose 2) are recorded as one. For the secondary outcome measures the two placebo arms are recorded separately.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline Factor II Concentrations by ECL Assay</measure>
    <time_frame>Predose and 1-8 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline Factor II Concentrations by Clot Assay</measure>
    <time_frame>Predose and 1-8 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline D-dimer Concentration</measure>
    <time_frame>predose and 1-8 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">157</enrollment>
  <condition>Healthy Subjects</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>MEDI8111</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo for MEDI8111</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>MEDI8111</intervention_name>
    <description>MEDI8111 lyophilisate for solution for infusion</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo for MEDI8111 saline solution for infusion</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Provision of signed and dated, written informed consent prior to any study specific
             procedures, Healthy male subjects aged 18-40 years with suitable veins for cannulation
             or repeated venepuncture, Have a body mass index (BMI) between 18 and 30 kg/m2
             inclusive and weight at least 50 kg an no more than 100 kg inclusive, Male subjects
             should be willing to avoid fathering a child by either true abstinence or the use of
             two effective means of contraception from the day of dosing until 3 months after
             dosing with the IP. They should also be willing to use barrier methods from the day of
             dosing until 3 months after dosing.

        Exclusion Criteria:

          -  Prothrombotic mutation such as factor V Leiden, or deficiencies of protein C, protein
             S, prothrombin, antithrombin or APC, Antibodies to coagulation FII, History or family
             history of venous or arterial thromboembolic event, and/or myocardial infarction
             before age of 50 years, ETP level at baseline &gt;2000nM/min, FII level (by clot) at
             screening and/or at baseline outside 50-250% of the normal range
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karin Wahlander, MD</last_name>
    <role>Study Director</role>
    <affiliation>AstraZeneca Mölndal, Sweden</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anders Berggren, MD</last_name>
    <role>Study Chair</role>
    <affiliation>AstraZeneca Mölndal, Sweden</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Timothy Mant, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Quintiles London, United Kingdom</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 7, 2013</study_first_submitted>
  <study_first_submitted_qc>October 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 9, 2013</study_first_posted>
  <results_first_submitted>October 22, 2015</results_first_submitted>
  <results_first_submitted_qc>January 5, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 4, 2016</results_first_posted>
  <last_update_submitted>January 5, 2016</last_update_submitted>
  <last_update_submitted_qc>January 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 4, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Phase 1, healthy male subjects, safety and tolerability, pharmacodynamic, pharmacokinetic</keyword>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Male healthy volunteers recruited by advertisement during the period October 2013 - October 2014</recruitment_details>
      <pre_assignment_details>The study was prematurely terminated after 2 cohorts as dose escalation stopping criteria (PD thresholds) were reached and it was judged to be of limited value to expose more healthy subjects.
Cohort 1: 2 placebo + 4 MEDI8111 dose 1. Cohort 2: 2 placebo + 4 MEDI8111 dose 2.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Placebo</title>
          <description>Placebo (Saline solution for infusion)</description>
        </group>
        <group group_id="P2">
          <title>MEDI8111 Dose 1</title>
          <description>MEDI8111 dose 1 (Lyophilisate for solution for infusion, 30 mg)</description>
        </group>
        <group group_id="P3">
          <title>MEDI8111 Dose 2</title>
          <description>MEDI8111 dose 2 (Lyophilisate for solution for infusion, 30 mg)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Placebo</title>
          <description>Placebo (Saline solution for infusion)</description>
        </group>
        <group group_id="B2">
          <title>MEDI8111 Dose 1</title>
          <description>MEDI8111 dose 1 (Lyophilisate for solution for infusion, 30 mg)</description>
        </group>
        <group group_id="B3">
          <title>MEDI8111 Dose 2</title>
          <description>MEDI8111 dose 2 (Lyophilisate for solution for infusion, 30 mg)</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="4"/>
            <count group_id="B2" value="4"/>
            <count group_id="B3" value="4"/>
            <count group_id="B4" value="12"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25" spread="9"/>
                    <measurement group_id="B2" value="30" spread="6"/>
                    <measurement group_id="B3" value="30" spread="6"/>
                    <measurement group_id="B4" value="29" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Description of the Safety Profile in Terms of Adverse Events (AE),Vital Signs, ECG, Lab Variables, Immunogenicity and Physical Examination</title>
        <time_frame>From screening and up to the lab follow-up visit (Day 29)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo (Saline solution for infusion)</description>
          </group>
          <group group_id="O2">
            <title>MEDI8111 Dose 1</title>
            <description>MEDI8111 dose 1 (Lyophilisate for solution for infusion, 30 mg)</description>
          </group>
          <group group_id="O3">
            <title>MEDI8111 Dose 2</title>
            <description>MEDI8111 dose 2 (Lyophilisate for solution for infusion, 30 mg)</description>
          </group>
        </group_list>
        <measure>
          <title>Description of the Safety Profile in Terms of Adverse Events (AE),Vital Signs, ECG, Lab Variables, Immunogenicity and Physical Examination</title>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Subjects with any AE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Gastrointestinal disorders</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Infections and infestations</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Investigations</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Musculoskeletal and connective tissue disorders</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nervous system disorder</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Respiratory, thoracic and mediastinal disorders</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Skin and subcutaneous tissue disorders</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline Endogenous Thrombin Potential (ETP)</title>
        <description>For the baseline variables and adverse events the two placebo arms (placebo dose 1 and placebo dose 2) are recorded as one. For the secondary outcome measures the two placebo arms are recorded separately.</description>
        <time_frame>Predose and Days 1-5</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo Dose 1</title>
            <description>Placebo dose 1 (Saline solution for infusion)</description>
          </group>
          <group group_id="O2">
            <title>MEDI8111 Dose 1</title>
            <description>MEDI8111 dose 1 (Lyophilisate for solution for infusion, 30 mg)</description>
          </group>
          <group group_id="O3">
            <title>MEDI8111 Dose 2</title>
            <description>MEDI8111 dose 2 (Lyophilisate for solution for infusion, 30 mg)</description>
          </group>
          <group group_id="O4">
            <title>Placebo Dose 2</title>
            <description>Placebo dose 2 (Saline solution for infusion)</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline Endogenous Thrombin Potential (ETP)</title>
          <description>For the baseline variables and adverse events the two placebo arms (placebo dose 1 and placebo dose 2) are recorded as one. For the secondary outcome measures the two placebo arms are recorded separately.</description>
          <units>nM*min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0.98 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16" spread="143"/>
                    <measurement group_id="O2" value="131" spread="219"/>
                    <measurement group_id="O3" value="NA">No sample was planned to be collected at this time point.</measurement>
                    <measurement group_id="O4" value="NA">No sample was planned to be collected at this time point.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.03 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.5" spread="138"/>
                    <measurement group_id="O2" value="145" spread="263"/>
                    <measurement group_id="O3" value="39.8" spread="72.1"/>
                    <measurement group_id="O4" value="-35.0" spread="214"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.25 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.0" spread="356"/>
                    <measurement group_id="O2" value="135" spread="345"/>
                    <measurement group_id="O3" value="211" spread="179"/>
                    <measurement group_id="O4" value="27.0" spread="80.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.5 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="166" spread="75"/>
                    <measurement group_id="O2" value="-17.3" spread="120"/>
                    <measurement group_id="O3" value="NA">No sample was planned to be collected at this time point.</measurement>
                    <measurement group_id="O4" value="NA">No sample was planned to be collected at this time point.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.5" spread="148"/>
                    <measurement group_id="O2" value="178" spread="336"/>
                    <measurement group_id="O3" value="147" spread="167"/>
                    <measurement group_id="O4" value="-79.5" spread="95.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.0" spread="238"/>
                    <measurement group_id="O2" value="188" spread="385"/>
                    <measurement group_id="O3" value="NA">No sample was planned to be collected at this time point.</measurement>
                    <measurement group_id="O4" value="NA">No sample was planned to be collected at this time point.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-88.0" spread="226"/>
                    <measurement group_id="O2" value="72.8" spread="545"/>
                    <measurement group_id="O3" value="157" spread="277"/>
                    <measurement group_id="O4" value="4.50" spread="48.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="157" spread="161"/>
                    <measurement group_id="O2" value="141" spread="288"/>
                    <measurement group_id="O3" value="83.0" spread="216"/>
                    <measurement group_id="O4" value="6.50" spread="33.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82.5" spread="70.0"/>
                    <measurement group_id="O2" value="366" spread="396"/>
                    <measurement group_id="O3" value="NA">No sample was planned to be collected at this time point.</measurement>
                    <measurement group_id="O4" value="NA">No sample was planned to be collected at this time point.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-29.0" spread="279"/>
                    <measurement group_id="O2" value="115" spread="336"/>
                    <measurement group_id="O3" value="86.0" spread="120"/>
                    <measurement group_id="O4" value="70.5" spread="14.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>36 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-59.0" spread="134"/>
                    <measurement group_id="O2" value="329" spread="496"/>
                    <measurement group_id="O3" value="NA">No sample was planned to be collected at this time point.</measurement>
                    <measurement group_id="O4" value="NA">No sample was planned to be collected at this time point.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.0" spread="222"/>
                    <measurement group_id="O2" value="172" spread="264"/>
                    <measurement group_id="O3" value="206" spread="261"/>
                    <measurement group_id="O4" value="91.0" spread="26.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>72 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="183" spread="222"/>
                    <measurement group_id="O2" value="71.5" spread="274"/>
                    <measurement group_id="O3" value="139" spread="194"/>
                    <measurement group_id="O4" value="73.5" spread="9.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-95.0" spread="209"/>
                    <measurement group_id="O2" value="-1.00" spread="483"/>
                    <measurement group_id="O3" value="64.8" spread="223"/>
                    <measurement group_id="O4" value="46.0" spread="8.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Follow up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-12.5" spread="13.4"/>
                    <measurement group_id="O2" value="-34.5" spread="206"/>
                    <measurement group_id="O3" value="NA">No sample was planned to be collected at this time point.</measurement>
                    <measurement group_id="O4" value="NA">No sample was planned to be collected at this time point.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline Factor II Concentrations by ECL Assay</title>
        <time_frame>Predose and 1-8 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo Dose 1</title>
            <description>Placebo dose 1 (Saline solution for infusion)</description>
          </group>
          <group group_id="O2">
            <title>MEDI8111 Dose 1</title>
            <description>MEDI8111 dose 1 (Lyophilisate for solution for infusion, 30 mg)</description>
          </group>
          <group group_id="O3">
            <title>MEDI8111 Dose 2</title>
            <description>MEDI8111 dose 2 (Lyophilisate for solution for infusion, 30 mg)</description>
          </group>
          <group group_id="O4">
            <title>Placebo Dose 2</title>
            <description>Placebo dose 2 (Saline solution for infusion)</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline Factor II Concentrations by ECL Assay</title>
          <units>umol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0.33 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.0810" spread="0.0410"/>
                    <measurement group_id="O2" value="-0.0188" spread="0.0661"/>
                    <measurement group_id="O3" value="NA">No sample was planned to be collected at this time point.</measurement>
                    <measurement group_id="O4" value="NA">No sample was planned to be collected at this time point.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0.67 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.0480" spread="0.0113"/>
                    <measurement group_id="O2" value="0.0275" spread="0.0377"/>
                    <measurement group_id="O3" value="NA">No sample was planned to be collected at this time point.</measurement>
                    <measurement group_id="O4" value="NA">No sample was planned to be collected at this time point.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0.98 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.134" spread="0.0368"/>
                    <measurement group_id="O2" value="0.00450" spread="0.0896"/>
                    <measurement group_id="O3" value="NA">No sample was planned to be collected at this time point.</measurement>
                    <measurement group_id="O4" value="NA">No sample was planned to be collected at this time point.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.131" spread="0.0156"/>
                    <measurement group_id="O2" value="-0.0305" spread="0.0435"/>
                    <measurement group_id="O3" value="0.166" spread="0.0632"/>
                    <measurement group_id="O4" value="0.0650" spread="0.0212"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.25 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.143" spread="0.00354"/>
                    <measurement group_id="O2" value="-0.0920" spread="0.0881"/>
                    <measurement group_id="O3" value="0.116" spread="0.113"/>
                    <measurement group_id="O4" value="0.0600" spread="0.0424"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.5 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.132" spread="0.121"/>
                    <measurement group_id="O2" value="-0.124" spread="0.148"/>
                    <measurement group_id="O3" value="NA">No sample was planned to be collected at this time point.</measurement>
                    <measurement group_id="O4" value="NA">No sample was planned to be collected at this time point.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.0655" spread="0.0629"/>
                    <measurement group_id="O2" value="0.00450" spread="0.188"/>
                    <measurement group_id="O3" value="0.111" spread="0.129"/>
                    <measurement group_id="O4" value="0.0800" spread="0.0849"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.0675" spread="0.248"/>
                    <measurement group_id="O2" value="0.0608" spread="0.120"/>
                    <measurement group_id="O3" value="NA">No sample was planned to be collected at this time point.</measurement>
                    <measurement group_id="O4" value="NA">No sample was planned to be collected at this time point.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.127" spread="0.279"/>
                    <measurement group_id="O2" value="0.123" spread="0.0663"/>
                    <measurement group_id="O3" value="0.141" spread="0.155"/>
                    <measurement group_id="O4" value="0.0450" spread="0.0495"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00650" spread="0.122"/>
                    <measurement group_id="O2" value="0.0633" spread="0.0801"/>
                    <measurement group_id="O3" value="0.0835" spread="0.0731"/>
                    <measurement group_id="O4" value="-0.00900" spread="0.0410"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline Factor II Concentrations by Clot Assay</title>
        <time_frame>Predose and 1-8 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo Dose 1</title>
            <description>Placebo dose 1 (Saline solution for infusion)</description>
          </group>
          <group group_id="O2">
            <title>MEDI8111 Dose 1</title>
            <description>MEDI8111 dose 1 (Lyophilisate for solution for infusion, 30 mg)</description>
          </group>
          <group group_id="O3">
            <title>MEDI8111 Dose 2</title>
            <description>MEDI8111 dose 2 (Lyophilisate for solution for infusion, 30 mg)</description>
          </group>
          <group group_id="O4">
            <title>Placebo Dose 2</title>
            <description>Placebo dose 2 (Saline solution for infusion)</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline Factor II Concentrations by Clot Assay</title>
          <units>% (concentration)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0.33 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.65" spread="26.4"/>
                    <measurement group_id="O2" value="-1.40" spread="7.67"/>
                    <measurement group_id="O3" value="NA">No sample was planned to be collected at this time point.</measurement>
                    <measurement group_id="O4" value="NA">No sample was planned to be collected at this time point.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0.67 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.15" spread="17.2"/>
                    <measurement group_id="O2" value="1.35" spread="6.95"/>
                    <measurement group_id="O3" value="NA">No sample was planned to be collected at this time point.</measurement>
                    <measurement group_id="O4" value="NA">No sample was planned to be collected at this time point.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0.98 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-9.35" spread="12.2"/>
                    <measurement group_id="O2" value="-2.40" spread="4.25"/>
                    <measurement group_id="O3" value="NA">No sample was planned to be collected at this time point.</measurement>
                    <measurement group_id="O4" value="NA">No sample was planned to be collected at this time point.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-14.4" spread="13.6"/>
                    <measurement group_id="O2" value="-1.15" spread="4.22"/>
                    <measurement group_id="O3" value="13.7" spread="14.5"/>
                    <measurement group_id="O4" value="7.30" spread="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.25</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.85" spread="18.6"/>
                    <measurement group_id="O2" value="-0.400" spread="5.54"/>
                    <measurement group_id="O3" value="12.2" spread="9.55"/>
                    <measurement group_id="O4" value="8.30" spread="1.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.5 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-10.9" spread="12.9"/>
                    <measurement group_id="O2" value="-0.400" spread="8.67"/>
                    <measurement group_id="O3" value="NA">No sample was planned to be collected at this time point.</measurement>
                    <measurement group_id="O4" value="NA">No sample was planned to be collected at this time point.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-8.85" spread="8.70"/>
                    <measurement group_id="O2" value="0.350" spread="5.45"/>
                    <measurement group_id="O3" value="10.5" spread="7.84"/>
                    <measurement group_id="O4" value="2.80" spread="4.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.85" spread="12.9"/>
                    <measurement group_id="O2" value="1.10" spread="9.73"/>
                    <measurement group_id="O3" value="NA">No sample was planned to be collected at this time point.</measurement>
                    <measurement group_id="O4" value="NA">No sample was planned to be collected at this time point.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.150" spread="15.8"/>
                    <measurement group_id="O2" value="2.10" spread="4.45"/>
                    <measurement group_id="O3" value="18.2" spread="9.02"/>
                    <measurement group_id="O4" value="7.30" spread="4.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-9.85" spread="10.1"/>
                    <measurement group_id="O2" value="-1.90" spread="5.78"/>
                    <measurement group_id="O3" value="11.7" spread="9.12"/>
                    <measurement group_id="O4" value="9.30" spread="4.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline D-dimer Concentration</title>
        <time_frame>predose and 1-8 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo Dose 1</title>
            <description>Placebo dose 1 (Saline solution for infusion)</description>
          </group>
          <group group_id="O2">
            <title>MEDI8111 Dose 1</title>
            <description>MEDI8111 dose 1 (Lyophilisate for solution for infusion, 30 mg)</description>
          </group>
          <group group_id="O3">
            <title>MEDI8111 Dose 2</title>
            <description>MEDI8111 dose 2 (Lyophilisate for solution for infusion, 30 mg)</description>
          </group>
          <group group_id="O4">
            <title>Placebo Dose 2</title>
            <description>Placebo dose 2 (Saline solution for infusion)</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline D-dimer Concentration</title>
          <units>mg/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0.98 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.0169" spread="0.0144"/>
                    <measurement group_id="O2" value="0.0408" spread="0.103"/>
                    <measurement group_id="O3" value="NA">No sample was planned to be collected at this time point.</measurement>
                    <measurement group_id="O4" value="NA">No sample was planned to be collected at this time point.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.03 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0432" spread="0.0564"/>
                    <measurement group_id="O2" value="0.0383" spread="0.109"/>
                    <measurement group_id="O3" value="0.0108" spread="0.0190"/>
                    <measurement group_id="O4" value="0.0270" spread="0.0141"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.25 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0232" spread="0.113"/>
                    <measurement group_id="O2" value="0.000750" spread="0.0336"/>
                    <measurement group_id="O3" value="0.0333" spread="0.0306"/>
                    <measurement group_id="O4" value="0.0170" spread="0.0566"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.5 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00185" spread="0.0214"/>
                    <measurement group_id="O2" value="0.408" spread="0.795"/>
                    <measurement group_id="O3" value="NA">No sample was planned to be collected at this time point.</measurement>
                    <measurement group_id="O4" value="NA">No sample was planned to be collected at this time point.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0682" spread="0.135"/>
                    <measurement group_id="O2" value="0.0382" spread="0.0813"/>
                    <measurement group_id="O3" value="0.0610" spread="0.0760"/>
                    <measurement group_id="O4" value="0.0170" spread="0.0424"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0732" spread="0.0846"/>
                    <measurement group_id="O2" value="0.00325" spread="0.0237"/>
                    <measurement group_id="O3" value="NA">No sample was planned to be collected at this time point.</measurement>
                    <measurement group_id="O4" value="NA">No sample was planned to be collected at this time point.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">No sample was planned to be collected at this time point.</measurement>
                    <measurement group_id="O2" value="NA">No sample was planned to be collected at this time point.</measurement>
                    <measurement group_id="O3" value="0.0933" spread="0.0810"/>
                    <measurement group_id="O4" value="0.207" spread="0.0849"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.588" spread="0.799"/>
                    <measurement group_id="O2" value="0.0858" spread="0.0914"/>
                    <measurement group_id="O3" value="0.0633" spread="0.0630"/>
                    <measurement group_id="O4" value="0.0470" spread="0.0849"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>At screening, Days 1-5</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Placebo</title>
          <description>Placebo (Saline solution for infusion)</description>
        </group>
        <group group_id="E2">
          <title>MEDI8111 Dose 1</title>
          <description>MEDI8111 dose 1 (Lyophilisate for solution for infusion, 30 mg)</description>
        </group>
        <group group_id="E3">
          <title>MEDI8111 Dose 2</title>
          <description>MEDI8111 dose 2 (Lyophilisate for solution for infusion, 30 mg)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia oral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Fibrin D-dimer increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Muscle contractions involuntary</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Increased upper airway secretion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4"/>
              </event>
              <event>
                <sub_title>Nasal congestion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Dermatitis contact</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Limitations: few subjects, high variability of coagulation variables</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Anders Berggren, MD, PhD</name_or_title>
      <organization>AstraZeneca</organization>
      <email>clinicaltrialtransparency@astrazeneca.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

